December 12, 2024 - 12:07

Recent research highlights the advantages of stock buybacks over traditional dividends in promoting financial stability within the banking sector. Conducted by SP Kothari, Hamid Mehran, and Zirui Song, the study suggests that share buybacks provide banks with greater flexibility, particularly during challenging economic times. Unlike dividends, which often create pressure for consistent payments and can lead to negative repercussions across the industry when reduced, buybacks allow institutions to tailor their capital distribution based on current conditions.
The findings indicate that banks engaging in buybacks can better navigate financial uncertainties without signaling distress to the market. This adaptability is crucial, as it helps maintain investor confidence and mitigates the risk of panic selling. By enabling banks to manage their capital more effectively, share buybacks serve as a more stable alternative to dividends, potentially enhancing the overall resilience of the banking system. As financial landscapes evolve, understanding these dynamics becomes increasingly important for stakeholders in the industry.
September 25, 2026 - 03:52
Campaign Finance Complaint Against Let's Go Washington DismissedA campaign finance complaint filed against the political action committee Let`s Go Washington has been dismissed after investigators found no evidence of unreported contributions tied to media...
September 24, 2026 - 22:27
Capital One Financial Corporation to Webcast Conference Call on Third Quarter 2026 EarningsMCLEAN, Va., September 24, 2026 -- Capital One Financial Corporation will report its third quarter 2026 financial results on Tuesday, October 20, 2026. The earnings release is scheduled for...
September 24, 2026 - 04:32
Federal Student Aid Forms for 2027-2028 Released Ahead of ScheduleThe U.S. Department of Education announced Wednesday that the Free Application for Federal Student Aid forms for the 2027-2028 academic year are now available. The release marks an earlier timeline...
September 23, 2026 - 09:02
VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?Viking Therapeutics has seen its stock outperform major competitors Eli Lilly and Novo Nordisk this month after releasing promising data on its experimental obesity treatment. The results have...